DEA schedule

Is Byfavo a controlled substance?

Byfavo contains remimazolam. Federal schedule from the FDA NDC directory, checked against the DEA controlled substances list.

Source: FDA NDC Directory file dated 2026-10-22. Publisher page

Yes. Byfavo (remimazolam) is a Schedule IV controlled substance under the federal Controlled Substances Act. Matching DEA list entry: Remimazolam (Schedule IV).

Run it in Rivvi

Which 2027 plans near you dropped or restricted Byfavo?

Tier changes and new prior auth, step therapy or quantity limits, plan by plan.

Free to start. Opens Rivvi, the AI workspace for healthcare teams.

Schedule check

Schedule sources for Byfavo
SourceWhat it lists
FDA NDC directory1 prescription listings from 1 labelers, all Schedule IV
DEA controlled substances listRemimazolam: Schedule IV

DEA list entry

DEA list entries for remimazolam
SubstanceDEA codeScheduleNarcoticOther namesMatch
Remimazolam (4H-imidazol[1,2-a][1,4]benzodiazepine-2846IVNo8-Bromo-1-methyl-6-(2-pyridinyl)-(4S)-methyl ester,Listed by name

Byfavo NDC listings

NDC listings for Byfavo
NDCProductFormStrengthLabelerDEA schedule
71390-011BYFAVOinjection, powder, lyophilized, for solution2.5 mg/mLAcacia Pharma, Ltd.CIV

Questions

Is Byfavo a controlled substance?

Yes. Byfavo (remimazolam) is a Schedule IV controlled substance under the federal Controlled Substances Act. Matching DEA list entry: Remimazolam (Schedule IV).

Is Byfavo a narcotic?

No. The DEA list does not mark remimazolam as a narcotic (NARC = N) and places it in Schedule IV.

What schedule is Byfavo?

Byfavo is Schedule IV in the FDA NDC directory, which matches the DEA controlled substances list.

Does this page cover state schedules?

No. This page reports the federal schedule only. Some states schedule drugs on their own; check your state board of pharmacy.

More on Byfavo

Try it on your own data today.

Free to start. Most teams are using it the same day.